TREATMENT OF PD-L1 POSITIVE LUNG CANCER USING AN ANTI-PD-1 ANTIBODY

• 收藏
• 分享

专利权人:

Bristol-Myers Squibb Company

发明人:

Friedrich FINCKENSTEIN

申请号：

US15577673

公开号：

US20180155429A1

申请日:

2016.05.27

申请国别(地区):

US

年份:

2018

代理人:

摘要：

This disclosure provides a method for treating a subject afflicted with a PD-L1 positive non-squamous non-small cell lung cancer (NSCLC). The method comprises administering to the subject a therapeutically effective amount of an anti-PD-1 anti-body or anti-PD-L1 antibody. In some embodiments, the non-squamous NSCLC tumor has a PD-L1 expression of at least about 1%. In some embodiments, the subject is additionally administered another anti-cancer agent.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/